Douglas R. Morton

2.8k citations
41 papers · 2.1k indexed · 2 hit papers · h-index 18

Douglas R. Morton

40 papers receiving 1.9k citations

Hit Papers

Slow-reacting substances, leukotrienes C4 and D4, increas...3581976202619922009100200300400500

Peers

Douglas R. Morton
Comparison fields: 5 of 112
  • Biochemistry 345
  • Pharmacology 575
  • Physiology 655
  • Immunology and Allergy 144
  • Organic Chemistry 421
Replace Yves Girard with:
Yves Girard Canada
Diane Ethier Canada
John G. Gleason United States
M. David Percival Canada
Zen‐ichi Terashita Japan
B. Wallmark Sweden
Daniel H. Albert United States
H. J. Keller Germany
Mark J. Rose United States
George W. Carter United States
Douglas R. Morton relative to Yves Girard Canada Yves Girard's profile →
Citations per field
00.5×1.5×2.0×
Yves Girard · 1×
Citations per year

Countries citing papers authored by Douglas R. Morton

Since Specialization
Citations

This map shows the geographic impact of Douglas R. Morton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas R. Morton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas R. Morton more than expected).

Fields of papers citing papers by Douglas R. Morton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas R. Morton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas R. Morton. The network helps show where Douglas R. Morton may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Douglas R. Morton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Douglas R. Morton Line = papers co-authored together Douglas R. Morton links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 198617
2
Inhibition of rat liver glutathione S-transferases by piriprost: kinetics of the inhibition and preliminary evidence that piriprost may be a poor alternative substrate for these enzymes.
19856
3
Chemistry of the prostaglandins and leukotrienes
19854
4 198484
5 1984119
6 198415
7 198312
8 198217
9
Slow-reacting substances, leukotrienes C4 and D4, increase the release of mucus from human airways in vitro.breakdown →
1982358
10 1982144
11 19827
12 19809
13 198018
14 19799
15 19786
16 197834
17 197819
18 19787
19 19786
20 19693

About Douglas R. Morton

Douglas R. Morton is a scholar working on Pharmaceutical Science, Organic Chemistry and Pharmacology, having authored 41 papers that have together received 2.1k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (9 papers), Oxidative Organic Chemistry Reactions (5 papers), Asthma and respiratory diseases (5 papers), Fluorine in Organic Chemistry (4 papers), Asymmetric Synthesis and Catalysis (3 papers), Glutathione Transferases and Polymorphisms (3 papers), Radical Photochemical Reactions (3 papers) and Immune Response and Inflammation (3 papers). The work is most often cited by research in Biochemistry (345 citations), Pharmacology (575 citations) and Physiology (655 citations). Douglas R. Morton has collaborated with scholars based in United States, Sweden and United Kingdom. Frequent co-authors include Robert R. Gorman, M K Bach, Zvi Marom, Michael Kaliner, James H. Shelhamer, James C. McGuire, Roy A. Johnson, John H. Kinner, Norman Whittaker and John R. Vane. Their work appears in journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026